Patent · US Expired

Galenical formulations

US5932243A · kind A · utility

74Cited by

13References

7Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Gerd Fricker · Staufen, DE
Barbara Haeberlin · Riehen, CH
Armin Meinzer · Glückstadt, DE
Jacky Vonderscher · Riedisheim, FR

Key dates

Filing date	Aug 22, 1997
Grant date	Aug 3, 1999
Priority date	—
Expiry date	Aug 22, 2017

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K47/44
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A pharmaceutical composition containing macrolide, e.g. a rapamycin compound in an emulsion preconcentrate or microemulsion preconcentrate for oral administration. The carrier medium for the rapamycin compound includes a hydrophilic phase, a lipophilic phase and a surfactant. The composition is stable and provides high absorption efficiency.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.